Category Archives: Food Supplements

By EDITORIALMore by this Author

The sudden death of Kenya rugby international Tony Onyango 12 days ago has given the Kenya Rugby Union and other sports federations serious food for thought regarding player safety. Onyango suffered a heart attack and died at his Nairobi home, moments after a training session. He had complained of chest discomfort and was advised to take a rest.

Onyangos is one among several cases in which young rugby players have died, principally from heart-related conditions.

Joshua Gathumbi collapsed and died after a match in 2010 while Victor Wayodi passed on during play in 2016, both from cardiac arrest.

Wayodi died barely a week after another player, Ogeto Gecheo, passed on after a freak injury in a league match.

These sudden deaths of rugby players, considered among the fittest in sport, is worrying. There are no local recent records where players from other sporting codes have suffered similar fate, which should trigger alarm bells at the Kenya Rugby Union.

Union officials must dig deep and identify the causes of these heart conditions and also come up with strict laws to protect players from fatal injuries.

With technological advancement and improvements in sports science, most players have embraced food supplements to enhance performance.

But some of these steroid products have adverse side effects with several having been banned by the World Anti-Doping Agency.

A good number of these supplements lead to high blood pressure and can easily make worse existing heart ailments that players may not be aware of, especially if not detected in good time.

Clubs must take the safety and health of their players first, for they are not robots.

The slightest sign of illness or discomfort should be addressed properly and conclusively.

See the original post:

Rugby deaths worrying - Daily Nation

How is it that perfectly respectable public-health initiatives, such as vaccines and water fluoridation, give rise to suspicion and conspiracy theories, while an entire industry thats telling us out-and-out falsehoods in order to take our money gets a free pass?

Dietary supplements, people! Where is the outrage?

Every year, Americans spend something like $35 billion on vitamins, minerals, botanicals and various other substances that are touted as health-giving but mostly do nothing at all. Nothing at all!

Could the entire category really just be a rip-off? I turned to the National Institutes of Health. I spoke with Carol Haggans, a scientific and health communications consultant with the Office of Dietary Supplements, about vitamins and minerals, and to Craig Hopp, deputy director of the National Center for Complementary and Integrative Health, about botanical and other kinds of supplements.

My question was the same: Which dietary supplements actually have well-established benefits?

Its a short list, Hopp told me. Ginger for nausea, peppermint for upset stomach, melatonin for sleep disruption. And fish oil does seem to show some promise for cardiovascular disease, although some of the data is conflicting. He went on to list some of the supplements that havent shown benefits in trials: turmeric, St. Johns wort, ginkgo, echinacea.

On the vitamin and mineral side, Haggans pointed out a couple of wins. Folic acid reduces risk for fetal neural tube defects, and it is widely recommended for women who may become pregnant. Vitamin B12 in food is sometimes poorly absorbed, she told me, and supplements can help in people over 50 (and vegans, because B12 comes from animal products). Then theres a combination supplement that may slow the progression of macular degeneration. Its also possible a daily multivitamin may decrease some disease risk.

Beyond that, supplements can help fill in a nutrient gap if you dont get enough, say, magnesium in your diet, but we dont have a lot of compelling evidence that using supplements to do that improves health outcomes.

I also checked in with Andrea Wong, senior vice president for scientific and regulatory affairs for the Council for Responsible Nutrition, a supplement industry group. She mentioned some of the same benefits and added that the Food and Drug Administration allows a health claim on calcium, or a combination of calcium and vitamin D, for reducing risk of osteoporosis.

That covers the noncontroversial territory, where both industry and independent scientists agree that theres at least some evidence of benefits. If youve got a favorite niacin? garlic? you could try to make the case. (If you want to investigate your supplement of choice, a good place to start is with NIH fact sheets.) This column is obviously too short to adjudicate every single one, but Hopps assessment stands: Its a short list.

But how about the vast expanse of shelves of dietary supplements that arent among those listed? The ones that purport to give you energy, support your immune system, stimulate hair growth or enlarge your penis? Wong points out that the FDA does regulate those claims; the agency requires that they have substantiation and be truthful.

You can hop on over to the FDAs website and read about what exactly constitutes substantiation, and youll find its a low bar. I have yet to talk to a scientist who takes dietary supplement claims seriously, so I asked Wong to refer me to one somebody with no ties to industry who believed the health claims made on dietary supplements were meaningful.

Readers, she couldnt.

Think about that for a second. The dietary supplements industry group couldnt point me to a single independent scientist who comes down on their side of this. Wong made the case that I shouldnt dismiss research out of hand just because its done by industry. And I agree, although I always take the funding source into consideration. But if the body of evidence were compelling, at least some independent scientists would be persuaded. Theyre not. Theyre just not.

On top of that, some dietary supplements can be downright harmful. Theres no requirement that supplement companies establish safety before they market their products, but they are required to report serious adverse events, and the FDA monitors those. If things get bad, they step in.

Peter Lurie, president of the Center for Science in the Public Interest, points to ephedra as the poster supplement for the harm the category can do. Its a substance that occurs naturally in some plants, and it was marketed as an appetite suppressant and energy booster. But then 155 people died, and the FDA took it off the market in 2003. But its the only dietary supplement that has been banned in the history of dietary supplements.

Lurie points out that even vitamins, which we think of as, at worst, benign, can increase disease risk: In trials, beta-carotene increased risk of lung cancer in smokers, and vitamin E increased risk of prostate cancer. According to Haggans, high doses of vitamin A can cause birth defects, and too much iron can even be fatal. With vitamins and minerals, she says, the main risk is getting too much.

Lurie is also concerned that we dont have a good way of knowing what damage supplements do. We have little safety information on the active ingredients, adulteration and contamination are real problems, and only serious adverse events are required to be reported to the FDA. Its more than reasonable to believe there may be dangerous products on the market; we just dont know what they are.

But take heart! The reassurance, such as it is, comes from the fact that the products are mostly ineffective, Lurie told me.

And thats the dietary supplement conundrum. Most of them do nothing, so you shouldnt take those. But the ones that actually do something are the ones that pose danger, so you shouldnt take those either. If something really can enlarge your penis, imagine the havoc it can wreak in your liver.

Thats the lay of the land. Supplements have very few benefits and some serious risks. So why do some three-quarters of Americans spend $35 billion on them every year?

I asked Alan Levinovitz, professor of religion at James Madison University and author of Natural: How Faith in Natures Goodness Leads to Harmful Fads, Unjust Laws, and Flawed Science (available in April). The first thing he pointed to was the pictures of fruits and leaves on the bottle, the emphasis on plant-based ingredients and the focus on naturalness. Think about the names medicines have, he said. Atorvastatin! Tramadol! They sound like alien space lords. Then look at supplements with names like Natures Way.

People feel comfortable with herbs and other botanicals, and they feel empowered by the idea that they make these choices for themselves. Youre like a sorcerer, said Levinovitz. Do I want to supercharge my brain or refresh my vitality? There couldnt be a more empowering place than the supplement aisle. The only problem, of course, is that none of its true.

Levinovitz sees ritual in supplement-taking; its a way to counterbalance the disempowerment of modern medicine. Its an unmet need, he told me, and he sees a parallel to prayer. How can we measure the value of those things? It makes no scientific sense, but what do we do about things that make no scientific sense but still matter to people?

Since people like supplements, and often think they do better with them than without them, Id be reluctant to issue an across-the-board no-supplements diktat even if I could. But I cant stop thinking about what people could do with that $35 billion. For starters, you could buy every man, woman and child a hefty (1/2 cup, dry) serving of lentils every single day. Not only would that be 24 grams of protein and 10 grams of fiber, it would be a whole days folate and hefty doses of thiamin, iron, phosphorous and zinc. Also soup. Take that, vitamin pill.

Alas, I dont think I can talk people into lentils any more than I can talk them out of dietary supplements. But maybe if someone could find a way to put them in a pill

See more here:

Most dietary supplements dont do anything. Why do we spend $35 billion a year on them? - Seattle Times

Having high levels of B12 might not be as good as it sounds. Getty

High levels of vitamin B12 in a person's blood are associated with an increased risk of early death, according to research published last month in the journal JAMA Network Open.

Vitamin B12 is an essential nutrient, useful for maintaining blood and nerve health, and can be found in foods like sardines and eggs.

However, researchers at the University of Groningen in the Netherlands analyzed 5,571 Dutch men and women with an average age of about 54 over about eight years and found that the people with the highest levels of B12 in their blood plasma were more likely to die earlier than those with the lowest levels their death rate was about twice as high.

The team was surprised to find the B12 connection held true even after controlling for other factors like age and history of cancer and heart disease.

The researchers said they weren't sure why, and while it may have something to do with the way B12 affects gut bacteria, they said that's just a guess.

People whose bodies cannot absorb vitamins like B12 through food can use supplements, and in recent years the market for vitamin and dietary supplements has boomed.

A 2013 article from the think tank McKinsey said it was partly because of an aging population and an increased consumer awareness of preventative healthcare. But not all preventative healthcare is good, and there is a growing body of scientific research exploring the detriments of vitamin supplements.

There isn't much scientific research backing up the hair-and-skin-strengthening benefits touted by many vitamin supplements. In fact, taking too many supplements can have adverse effects, and a 2015 study estimated that each year 23,000 people in the US visit the emergency room because of supplement-related issues.

A 2019 study found that for already healthy people, taking vitamin supplements isn't likely to do much. Another 2019 study found that taking too much vitamin D was associated with a higher risk of early death.

Many vitamin supplements aren't approved by the Food and Drug Administration. And for the ones that are, the FDA warns that their benefits are limited. The agency said in its latest B12 guidelines that "the body's ability to absorb vitamin B12 from dietary supplements is largely limited" and that "only about 10 mcg of a 500 mcg oral supplement is actually absorbed in healthy people."

Be leery of supplements, S. Bryn Austin, a professor of behavioral sciences at the Harvard T. H. Chan School of Public Health, previously told Business Insider.

"We don't have any clear evidence that they're beneficial," she said. "Whether it's on the bottle or not, there can be ingredients in there that can do harm."

The rest is here:

High levels of B12 were associated with an increased risk of early death in a new study - Insider - INSIDER

Feb. 20, 2020 14:00 UTC

Products within the SigNature and CertainT Brand Certified in Strict Compliance with OU Standards as Ingredients for Dietary Supplements, Pharmaceuticals and Food Products

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (Applied DNA, the Company, NASDAQ: APDN), announced receipt of certification from the Orthodox Union (OU) for products within the SigNature and CertainT line following a thorough evaluation of the Companys products and manufacturing processes. The Pareve kosher designation will first be used for the Nutrition21 Nitrosigine sports supplement product recently announced. The Companys products and services, used by its customers to manage traceability and authenticity in the name of brand assurance, are also suitable for related markets such as food and pharmaceuticals.

The OU (Orthodox Union) Kosher is the worlds largest and most widely recognized international kosher certification agency, certifying over 800,000 products produced in more than 9,011 plants located in 104 countries around the world. Over $150 billion of kosher certified products are consumed annually, with the OU kosher symbol appearing on close to 70% of Americas kosher certified foods.

As we grow our presence in food, pharmaceutical and dietary supplements markets, we are pleased to be supportive of the business imperatives critical to meet market requirements that maximize adoption. We are proud to have the OU certification on our qualifying products. OU maintains strict guidelines for certification and ongoing manufacturing, marketing and distribution of products, making Applied DNAs mission for enabling our customers a platform for proof of authenticity and traceability nicely complementary for OU-certified products, said Dr. James Hayward, president and CEO, Applied DNA.

The Companys qualifying CertainT and SigNature molecular tags enable companies and their supply chains to designate a unique molecular identity to products with meaning specific to the tagged material: for example, geographic facility location, brand, product line or date of manufacture. This tag can be blended into ingredients and packaging inks and varnishes in the pharmaceutical, nutraceutical, and dietary supplements industry. The tag enables its carrier to be verified for authenticity and blending detection, either at the customer or in the Applied DNA laboratory, depending on application requirements.

Applied DNA Sciences is leading the way in supply chain authentication, commented Rabbi Menachem Genack, CEO, OU Kosher, and we are excited to partner with them as they expand into the market of dietary supplements, food ingredients and nutraceuticals. In turn, he observed, their molecular tag offers our supervision program an additional instrument for validating the integrity of our certified products.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Common stock listed on NASDAQ under the symbol APDN.

Forward-Looking Statements

The statements made by Applied DNA in this press release may be forward-looking in nature within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNAs future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our ability to successfully enter into commercial contracts for the implementation of our CertainT platform, the possibility of failure to make timely payment on its outstanding secured convertible notes and resulting enforcement by noteholders of remedies on collateral which includes substantially all of Applied DNAs assets, the Companys history of net losses, limited financial resources, limited market acceptance and various other factors detailed from time to time in Applied DNAs SEC reports and filings, including our Annual Report on Form 10-K filed on December 12, 2019 and our subsequent quarterly report on Form 10-Q filed on February 6, 2020, and other reports we file with the SEC, which are available at http://www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005089/en/

Here is the original post:

Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products - BioSpace

Focus on select sub-segments remains core strategy of Dietary Supplements market players due to their potential for growth in the next few years, notes OGAnalysis new report launched in December 2019.

Request Dietary Supplements Market Sample @ https://www.oganalysis.com/sample/213294

The industry is concentrated significantly in unorganized space but growing food expenditure in emerging nations is encouraging foreign companies to rapidly expand their investment in domestic Dietary Supplements markets.

On the developed markets front, drive towards organic and healthy food and beverages is shaping the product portfolio of Dietary Supplements companies. Majority of Dietary Supplements manufacturers are investing in Research and Development to market healthy products. Further, acquisition of local players is also increasingly being observed as part of inorganic business expansion strategy worldwide.

Diversifying distribution channels with increasing presence of online and retail chains also acts as market driver, predominantly in developing countries. Shifting preferences towards new flavours, new taste and convenience are set to shape the Dietary Supplements product offerings over the medium term future.

Browse Dietary Supplements Market Report @ https://www.oganalysis.com/industry-reports/213294/dietary-supplements-market

Global Dietary Supplements market Insights

Key trends shaping the near and long term future of the industry, drivers, opportunities and restraints of Dietary Supplements market, detailed porters five forces analysis and competitive insights are included in the research.

Global Dietary Supplements market size by type

The 2020 series of global Dietary Supplements market size, share, outlook and growth prospects is a comprehensive analysis on global Dietary Supplements market conditions. The report presents the detailed annual outlook of each of the sub segments of Dietary Supplements across markets to 2026.

Global Dietary Supplements market share by applications

Amidst increasing emphasis on new applications and stagnant growth of conventional large applications, the report presents in-depth insights into each of the leading Dietary Supplements end user verticals along with annual forecasts to 2026

Request for Special Discount on Dietary Supplements Market Report https://www.oganalysis.com/discount/213294

Global Dietary Supplements market revenue by country

The current Dietary Supplements market size in terms of revenue across 12 countries, along with historic data from 2018 and annual forecasts to 2026 are included in the research. The countries included span across Asia Pacific, Europe, Middle East Africa, North America and South & Central America regions.

Global Dietary Supplements market analysis by Company

Top 10 leading companies in global Dietary Supplements market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and Dietary Supplements products and services.

Global Dietary Supplements market news and recent developments

Latest news and industry developments in terms of Dietary Supplements capacity expansions, acquisitions, organic and inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.

About OG Analysis:

OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions.

Contact Us:

Ambarish

Phone: +1 860 777 1418, +91-7337 01 3757

Email: [emailprotected]

Website: https://www.oganalysis.com

Follow Us on LinkedIn: https://www.linkedin.com/company/og-analysis/

Link:

Dietary Supplements Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026 - Nyse Nasdaq Live

When you buy a carton of milk, you may notice that some brands state on the front of the label that they contain vitamin D.

In reality, almost all pasteurized cows milk, as well as many brands of milk alternatives, have vitamin D added. Its required to be listed on the ingredient label but not necessarily on the front of the carton.

Vitamin D has many important health benefits, and drinking vitamin D fortified milk is an easy way to help meet your needs.

This article reviews why most milk has added vitamin D and why that might be good for you.

The recommended Daily Value (DV) for vitamin D is 800 international units (IU), or 20 mcg per day for all adults and children over 4 years old. For children aged 13, its 600 IU or 15 mcg per day (1).

With the exception of fatty fish like salmon, which contains 447 IU in a 3-ounce (85-gram) serving, very few foods are good sources of vitamin D. Instead, most vitamin D is made in your body when your skin is exposed to the sun (2).

Many people dont meet the recommendations for vitamin D. In fact, one study found that 25% of Canadians dont meet their needs through diet alone (3).

People who live in northern latitudes where sunshine is limited in the winter, as well as those who dont spend much time in the sun, often have lower blood levels of vitamin D (2, 3).

Other factors, such as having obesity or underweight, being physically inactive, and having certain genetic mutations, can also put you at risk of having lower vitamin D levels (4).

Taking a supplement and using fortified foods like vitamin D milk are good ways to increase your intake and blood levels of vitamin D.

You get vitamin D from sun exposure and your diet. However, many people dont get the recommended amount from their diet. Eating fortified foods like vitamin D milk can help close the gap.

In some countries, including Canada and Sweden, vitamin D is added to cows milk by law. In the United States, its not mandated, but most milk manufacturers add it voluntarily during milk processing (5).

It has been added to cows milk since the 1930s when the practice was implemented as a public health initiative to reduce rickets, which causes poor bone development and deformities in children (6).

While milk doesnt naturally contain vitamin D, its a good source of calcium. These two nutrients work well together, as vitamin D aids calcium absorption into your bones, thus helping strengthen them.

The combination of calcium and vitamin D also helps prevent and treat osteomalacia, or soft bones, which accompanies rickets and can affect older adults (7, 8).

The Food and Drug Administration (FDA) allows manufacturers to add up to 84 IU per 3.5 ounces (100 grams) of vitamin D3 to both cows milk and plant-based milk alternatives (9).

Drinking vitamin D milk increases the amount of vitamin D people get and improves levels of vitamin D in the blood (5).

Studies in Finland, where vitamin D milk has been mandatory since 2003, found that 91% of milk drinkers had vitamin D levels at or above 20 ng/ml, which is considered sufficient according to the Institute of Medicine (7, 10).

Prior to the fortification law, only 44% had optimal vitamin D levels (7, 10).

Vitamin D milk is enhanced with vitamin D during processing. This vitamin is added because it works with the calcium in milk to strengthen your bones. Drinking vitamin D milk can also help boost your vitamin D levels.

Drinking milk that contains both calcium and vitamin D is recommended as a way to strengthen your bones and prevent rickets and osteomalacia (8).

However, large studies dont show that it helps prevent osteoporosis, which is characterized by a thinning of the bones, or bone fractures in older adults (11, 12).

Still, having higher levels of vitamin D is linked to important health benefits and they extend beyond improved bone health.

Vitamin D is needed for proper cell growth, nerve and muscle function, and a healthy immune system. It likewise helps reduce inflammation, which is thought to contribute to conditions like heart disease, diabetes, autoimmune diseases, and cancer (2).

Studies that have compared vitamin D levels with disease risk suggest that having lower blood levels of the vitamin is linked to a higher risk of a wide range of chronic diseases, while having adequate or higher levels seems to result in a lower risk (13).

A major risk factor for heart disease is a cluster of conditions known as metabolic syndrome. It includes high blood pressure, insulin resistance, excess abdominal weight, high triglycerides, and low HDL (good) cholesterol.

People who have higher levels of vitamin D tend to have less severe metabolic syndrome and a lower risk of heart disease (13).

Additionally, higher levels of vitamin D are linked to healthier blood vessels (14).

A study in nearly 10,000 people found that those who got more vitamin D from supplements or diet including fortified milk had higher blood levels of the vitamin, less stiffness in their arteries, and lower blood pressure, triglyceride, and cholesterol levels (14).

Because vitamin D plays a major role in healthy cell division, development, and growth, its thought that it may also play a role in preventing the growth of cancer cells.

Research that looked at vitamin D levels and cancer risk in 2,300 women over the age of 55 found that blood levels greater than 40 ng/ml were associated with a 67% lower risk of all types of cancer (15).

Furthermore, Australian scientists who followed 3,800 adults for 20 years found the same benefit for breast and colon cancer, but not all types of cancer (16).

Though these studies looked only at vitamin D levels and not how the vitamin was obtained, a review of studies investigating the link between dairy milk and cancer found that it was protective against colorectal, bladder, stomach, and breast cancer (17).

Low vitamin D levels are often observed in those with autoimmune diseases, including: (18)

Its unclear whether low levels trigger or are a result of autoimmune disease, but some research suggests that getting more vitamin D in your diet may help prevent or manage these conditions.

Interestingly, some research on type 1 diabetes suggests that children who get more vitamin D early in life are at a lower risk of this condition (19).

Additionally, taking supplemental doses of vitamin D has been shown to improve symptoms and slow the progression of some autoimmune diseases like psoriasis, multiple sclerosis, rheumatoid arthritis, and autoimmune thyroid disease (20, 21, 22, 23).

In addition to helping maintain bone health, vitamin D plays many important roles in your body. Getting more vitamin D from fortified milk or other sources may help reduce your risk of heart disease, cancer, and autoimmune diseases.

For the most part, dairy and plant-based milks that are fortified with vitamin D contain similar levels of the vitamin.

Below are the amounts of vitamin D in a 1-cup (237-ml) serving of various types of milk (24, 25, 26, 27, 28, 29, 30, 31, 32, 33):

Milk thats not fortified with vitamin D, as well as human breast milk, are very low in the vitamin, so those who drink these unfortified milks should try to get their vitamin D from oily fish or a supplement.

The risk of getting too much vitamin D from fortified milk is extremely low.

Vitamin D toxicity occurs when more than 150 ng/ml of the nutrient are present in your blood, which generally only happens in people who take high doses of vitamin D in supplemental form over a long period without regularly having their blood levels checked (34).

All processed dairy milk and many milk alternatives are fortified with about 100 IU of vitamin D per serving. Raw milk has nothing added to it, so its inherently very low in vitamin D.

While not all milk manufacturers list so on the front label, almost all processed dairy milk is enriched with vitamin D.

In the United States, its not mandatory to add it to milk, but most producers add about 100 IU of vitamin D to each 1-cup (237-ml) serving. Some countries like Canada do mandate that milk is fortified.

Drinking vitamin D can help boost your levels of the vitamin, which is important for bone health. Plus, it may reduce your risk of chronic illness, including heart disease, cancer, and autoimmune conditions.

Read the rest here:

Vitamin D Milk: Everything You Need to Know - Healthline

Pune, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The global Dehydrated Potato Market size is slated to touch USD 8.84 billion by 2026, exhibiting a CAGR of 6.83% during the forecast period. Growing awareness regarding the nutritional value of instant potatoes and their variants is expected to be one of the central Dehydrated Potato Market trends in the upcoming decade. Instant potatoes are emerging as a viable alternative to regular potatoes in a world where hectic lifestyles have become a norm, which is taking a heavy toll on physical health. The US Department of Agriculture recommends a weekly intake of 5 to 6 cups of natural starch.

Dehydrated potatoes can fulfill this bodily requirement, delivering almost the same amount of nutrients like regular potatoes, except in a more convenient and efficient manner. These foods also contain the three essential macronutrients carbohydrates, proteins, and fats delivering the daily dose of energy required by the human body to function. Moreover, according to the US Agency for International Development, instant potato products such as potato flakes are a good source of starch in cases of emergency. Thus, the instant potato market stands to benefit as people become more aware of the healthy properties of these products.

Fortune Business Insights shares this information and more in its new report, titled Dehydrated Potatoes Market Size, Share & Industry Analysis, By Form (Flakes, Powder, Dices, Shreds, and Others), Nature (Organic and Conventional), By Distribution Channel (Food Services and Retail Channel), and Regional Forecasts, 2019 2026. As per the report, the value of this market stood at USD 5.23 billion in 2018.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dehydrated-potato-market-102186

The report also includes:

Gathering Pace of Urbanization Worldwide to Escalate the Demand for Ready-to-Eat Foods

The number of people living in urban areas is rising at a steady pace all around the globe as a result of economic growth and development, especially in developing nations. The UNs Department of Social and Economic Affairs predicts that Asian and African countries will account for around 90% of the rise in the global urban population by 2050. The birth of knowledge-based economies has created jobs in cities and metros that usually require people to sit in one place and perform data collection and analysis tasks on a daily basis.

Consequently, sedentary lifestyles have become commonplace and lives have gotten faster, both of which are adversely affecting human health. With little time to spare for cooking, consumer preference in urban areas is increasingly shifting towards ready-to-eat products, such as dehydrated potatoes, to meet the daily energy needs of the body.

Browse Detail Market Insights with Table of Content, Tables, and Figure: https://www.fortunebusinessinsights.com/dehydrated-potato-market-102186

List of Prominent Players Covered in the Dehydrated Potatoes Market Research Report are;

Increasing Population to the Drive the Market in Asia-Pacific

Among regions, Asia-Pacific is forecasted to dominate the Dehydrated Potato Market share in the coming decade owing to the rapidly rising populations in India and China. These countries also have a steadily expanding middle class that is actively consuming nutrition-laden processed foods. Furthermore, China and India are some of the largest producers of potatoes in the world, which will aid the instant potatoes market growth in the region. Lastly, the large consumer base is attracting companies from developed nations to establish themselves in this fledgling market, thereby accelerating the Dehydrated Potato Market revenue during the forecast period.

Competitors to Focus on Upgrading Production Capacities and Diversifying Operations

Major players are directing their investments towards enhancing their production capabilities and expanding their operational range, according to the instant potatoes market analysis. This would provide the companies with a solid base for building their brand value in this market.

Order a Single User License Copy: https://www.fortunebusinessinsights.com/checkout-page/102186

Detailed Table of Content:

TOC Continued!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/dehydrated-potato-market-102186

Industry Developments:

Have a Look at Related Market Insights:

Functional Water Market Size, Share and Industry Analysis By Ingredient (Micronutrients, Botanical Extracts, Other Functional Ingredients), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Online Retail, Others), and Regional Forecast 2018-2025

Potato Starch Market Size, Share & Industry Analysis, By Nature (Organic and Conventional), End-use (Textile & Paper, Food & Beverages, and Pharmaceuticals), Type (Native and Modified), and Regional Forecast 2019-2026

Europe Dietary Supplements Market Size, Share & Industry Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets, Capsules, Powder, and Liquid), and Regional Forecasts, 2019 2026

Carotenoids Market Share, Size and Global Trend by Product Type (Beta-Carotene, Lutein, Astaxanthin, Zeaxanthin, Lycopene, Canthaxanthin), Application Type (Food & Beverages, Animal Feed, Pharmaceuticals, Cosmetics, Dietary Supplements, Other Applications), Source (Natural, Synthetic) and Geography Forecast till 2025

Savory Ingredients Market Share, Size and Global Trend By Source (Natural, Synthetic), Product (Yeast Extracts, Monosodium Glutamate, Protein, Nucleotides), Application (Food, Animal Feed) & Geography Forecast till 2026

Essential Oils Market Share, Size and Global Trend By Type (Citrus, Eucalyptus, Lavender, Rosemary, Tea Tree, and Others), Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, and Others), and Geography Forecast till 2026

Probiotics Market Size, Share and Industry Analysis By Microbial Genus (Lactobacillus, Bifiodobacterium, Yeast), By Application (Functional Food and Beverage, Dietary Supplement, Animal Feed), By Distribution Channel (Supermarkets/Hypermarkets, Pharmacies/Health Stores, Convenience Stores, Online Retail), and Regional Forecast 2018 2025

Plant Based Protein Supplements Market Size, Share and Industry Analysis By Type (Soy Protein, Pea Protein & Wheat Protein), By Distribution Channel (Mass Merchandisers, Pharmacies/Drugstores, Specialty Stores, Online Retail & Others), and Regional Forecast 2018-2025

Commercial Seaweed Market Size, Share and Industry Analysis By Product Type (Red Seaweed, Brown Seaweed, Green Seaweed), By Form (Flakes, Powder, Liquid), By End User (Food and Beverage, Agricultural Fertilizer, Animal Feed Additives, Pharmaceuticals, Cosmetics and Personal Care), and Regional Forecast 2018-2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.Phone:US: +1 424 253 0390UK: +44 2071 939123APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business InsightsLinkedin | Twitter | Blogs

Read Press Release on Dehydrated Potato Market: https://www.fortunebusinessinsights.com/press-release/dehydrated-potato-market-9599

See the article here:

Dehydrated Potatoes Market Size to Hit USD 8.84 Billion by 2026; Rising Preference for Nutrition-rich Processed Foods to Boost Sales Opportunities:...

There is debate over whether CBD oils offer health benefits, which can be attributed to its rising popularity. But the assessment of CBD oils is a complex task, particularly due to the potential for oils to contain undeclared traces of delta-9-tetrahydrocannabinol. Six experts from the University of Chemistry and Technology, Prague, present their research.

The popularity of cannabidiol (CBD) oils is growing exponentially owing to their association with numerous health benefits and even miraculous healing properties. However, some CBD oils may also present several problems, especially in terms of their safety, due to the presence of undeclared delta-9-tetrahydrocannabinol (9-THC).

Phytocannabinoids, along with terpenes and terpenoids, are the major biologically active secondary metabolites of Cannabis sativa L., which are being extensively studied due to their potential therapeutic effects. In the cannabis plant, phytocannabinoids commonly occur in the form of carboxylic acids,1 from which neutral forms possessing the desired therapeutic effect originate (via decarboxylation). This process is mostly induced by high temperatures.2 However, the activation of phytocannabinoid acids is accompanied by a variety of other reactions that can affect the resulting biological activity of Cannabis extracts.3

Over 20 percent of the tested CBD oils contained less CBD than declared by the manufacturer.

The most extensively studied phytocannabinoids are CBD and 9-THC. The latter is the main hallucinogenic compound of Cannabis sativa L. and, therefore, is legislatively regulated worldwide as a narcotic substance. Contrary to 9-THC, CBD does not exhibit hallucinogenic effects and is currently attributed with having significant therapeutic potential. Its beneficial characteristics include being antiepileptic, antibacterial, antidiabetic, analgesic, anti-inflammatory, immunosuppressive, neuroprotective, antipsychotic and anti-cancer, among many others.1 CBD is also able to reduce the psychotropic effects of 9-THC.4

It has long been believed that CBD is completely non-toxic, but according to a warning recently issued by the US Food and Drug Administration (FDA), it can cause liver damage.5 When used as a medicine in cases where patients are under professional medical supervision, this negative effect from CBD can be monitored and avoided. Despite this, there is a wide range of CBD-enriched products (and even pure CBD crystals) freely available on the market, the most popular of which are CBD oils.

When using Cannabis and derived products as a medicine, the presence of several other biologically active compounds besides CBD and 9-THC should be considered. According to Russo,3 all these substances are involved in the overall biological effect; the synergic actions of phytocannabinoids and terpenes termed the entourage effect play an especially important role. As an example, this was demonstrated on two Cannabis varieties with the same CBD and 9-THC content, one of which shows therapeutic effects and the other not.3

Commonly, CBD oils are made of various edible vegetable oils enriched with natural decarboxylated extract of the Cannabis plants (up to 50 percent of extract) or in some cases purified CBD (natural or synthetic) is dissolved in oil.6 There are dozens of such CBD products on the market with contents that vary from tenths to dozens in weight percentage (wt.). Although, in most cases, not declared on the label, CBD oils may contain relatively high levels of 9-THC, which may pose a risk for consumers. The other health risk documented in our recent studies is the presence of carcinogenic polycyclic aromatic hydrocarbons (PAHs).7

Even Cannabis plants specially bred for high CBD content contain at least trace amount of 9-THC. As most isolation procedures whether supercritical fluid extraction (SFE) or ethanolic extraction are rather nonselective, all lipophilic cannabis components, including the undesirable 9-THC, are substantially concentrated.

If no further purification of CBD is performed, then the psychotropic 9-THC content becomes unacceptably high, putting CBD oil consumers at unexpected risk. This includes positive outcomes in drug testing, which could have serious consequences for drivers (ICCI web).

Approximately 60 percent of the tested CBD oils exceeded the legislation limits for PAH levels.

Between 2016 and 2019, the University of Chemistry and Technology in Prague (UCT Prague), under the auspices of the International Cannabis and Cannabinoids Institute (ICCI), analysed 70 CBD oils from EU markets.8,9 More than 20 percent of those CBD oils contained less CBD than declared by the manufacturer. Regarding 9-THC content, more than 90 percent of the samples contained this psychotropic compound at a concentration greater than 0.2 weight by weight (w/w) percent (EU legislative limits for dry hemp plants). However, only a few of these products provided information about 9-THC occurrence on the label.

These results correspond to the results of a study by Pavlovic et al.;10 in which 14 CBD oils from the European market were analysed, nine of them having a deviation of over 10 percent from the manufacturers declared CBD content. Furthermore, 12 out of 14 samples contained hallucinogenic 9-THC (0.0036-0.35 wt. percent).10 Some of the tested oils also contained high levels of cannabidiolic acid (CBDA) and the declared CBD content was reported by the manufacturer as [CBD] + 0.877 * [CBDA]. As CBDA is a biologically inactive form of CBD,1 its content in the ready-to-eat product (which is not intended to experience heat treatment, and therefore not expected to produce CBDA decarboxylation before consumption) should not be reflected in the total CBD content. It is worth noting that the European Food Safety Authority (EFSA) has established an acute reference dose (ARfD) of 9-THC 1 g/kg body weight an amount of 9-THC, which can be taken daily without a risk. For an average person weighing 70kg, this dose is 70g 9-THC.11

In the aforementioned CBD oils testing performed by UCT Prague and ICCI, half of the products containing 9-THC exceeded the ARfD (70g 9-THC) when taking the daily dose recommended by the producer. In the case of the most 9-THC-potent CBD oil (9-THC 0.35 percent w/w) analysed in the Pavlovic study,10 the ARfD for a person weighing 70kg is already exceeded after consuming 20mg (about one drop) of this oil.

Polycyclic aromatic hydrocarbons (PAHs) are carcinogenic compounds that largely originate during combustion processes through pyrolysis of organic matter. They enter the environment due to various emission sources, and when improper food processing practices are used, they may also contaminate products intended for human consumption.12 According to Commission Regulation (EU) 2015/1933 of 27 October 2015, a maximum limit has been set for benzo (a) pyrene (2 g/kg) and for the sum of four of the most carcinogenic PAHs, namely benzo(a)pyrene, benzo(a)anthracene, benzo(b)fluoranthene and chrysene (10 g/kg) in edible oil-based food supplements.

During UCT Pragues and ICCIs study on the quality of CBD oils in the European market, the presence of PAHs was also controlled, and rather alarming results were obtained. Approximately 60 percent of tested CBD oils exceeded the legislation limits. The source of PAHs contamination is probably the Cannabis plant material used for extract preparation. Similarly to phytocannabinoids, PAHs are lipophilic compounds and thus can be co-extracted together from the plant material. Contamination is likely to occur during a poor drying process (in the presence of smoke) or from dust in which elevated levels of PAHs that adhere to the plant during storage are present.13

The preparation of CBD oils using synthetic CBD instead of the plant extract results in a lack of other naturally occurring phytocannabinoids and bioactive compounds involved in the entourage effect, which may have a decisive influence on the therapeutic effect of the product.3

Cannabis and cannabis product legislation is quite diverse. In the EU, Regulation (EC) No 1307/2013 allows legally grown Cannabis plants with a low 9-THC content (<0,2 w/w percent dry matter) for hemp fibre production. Furthermore, only the varieties registered in the Common Catalog of Varieties of Agricultural Plant Species are allowed to be grown for industrial use.15 In terms of medical Cannabis, the situation is also problematic and each country has their own legislative regulations. However, more countries are retreating and allowing the growing and use of Cannabis for medicinal purposes.14

More complex clinical studies on the long-term effects of phytocannabinoids on human health must be conducted in the near future.

Almost all legislative regulations control 9-THC, while CBD is mostly unregulated. An exception is Slovakia, where CBD belongs to the group of banned and psychotropic compounds along with 9-THC, methamphetamine, cocaine and other harddrugs (Act No. 139/1998 (the Narcotics Act)) since 2011. The first major step in the ongoing effort of the other European countries to regulate CBD is to introduce CBD into the EU novel food catalogue.

Novel foods are defined as foods that have not been extensively consumed in the EU prior to 15 May 1997, when the first novel foods regulation came into force (Regulation (EU) 2015/2283 on novel foods). Regarding Cannabis, the novel foods catalogue reads: Without prejudice to the information provided in the novel food catalogue for the entry relating to Cannabis sativa L., extracts of Cannabis sativa L. and derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated. This applies to both the extracts themselves and any products to which they are added as an ingredient (such as hemp seed oil). This also applies to extracts of other plants containing cannabinoids. Synthetically obtained cannabinoids are considered as novel.16 It means that CBD oils fall within the definition of a novel food and thus, the enrichment of edible oils with Cannabis extract makes it a new food product, which must undergo a safety assessment and registration process before being legally placed on the market.

The results available have, so far, shown that CBD oils need to be monitored for their quality and safety. Besides the (non)compliance with the declared CBD content, the most serious issue is currently the high content of psychotropic 9THC in these products. Also, the compliance of PAHs content with maximum levels (Commission Regulation (EU) 2015/1933 of 27 October 2015) should be controlled to avoid health risks associated with these hazardous contaminants. Finally, the warning published recently by the FDA regarding possible liver injury must also be taken into consideration.

Under these conditions, the assessment of CBD oils quality is a rather difficult task, as uniform criteria against which the safety of CBD-based products can be assessed are missing. More complex clinical studies on the long-term effects of phytocannabinoids on human health must be conducted in the near future.

Frantisek Benes

Frantisek Benes is aPhD student at the University of Chemistry and Technology, Prague. His activities are mainly focused on utilisation of various liquid chromatography- mass spectrometry-based instrumental techniques for analysis of bioactive compounds in various natural products and biological samples. Frantisek has expertise in the analysis of phytocannabinoids and other bioactive compounds present in Cannabis sativa L. and products thereof.

Marie Fenclova

Marie Fenclova PhD is a research assistant at the University of Chemistry and Technology, Prague. She is focusing on the utilisation of liquid chromatography-mass spectrometry-based instrumental techniques for the quantitative and screening analysis of beneficial bioactive compounds and contaminants in various natural products and biological samples.

Petra Peukertova

Petra Peukertovais a researcher at the University of Chemistry and Technology, Prague. Her main research area includes analysis of phytocannabinoids and other bioactive compounds in Cannabis sativa L. and products thereof, using liquid chromatography-mass spectrometry-based instrumental techniques.

Zuzana Binova

Zuzana Binovais a PhD student at the University of Chemistry and Technology, Prague. Her study is mainly focused on analysis of phytocannabinoids in Cannabis sativa L. and phytocannabinoid metabolites in various biological samples using liquid chromatography-mass spectrometry-based instrumental techniques.

Zbynek Dzuman

Zbynek Dzuman PhD works as a research assistant at the University of Chemistry and Technology, Prague. His main research area includes targeted analysis of bioactive compounds, natural toxins (mycotoxins and plant alkaloids) and pesticide residues in food, feed and dietary supplements, using liquid chromatography and mass spectrometry.

Professor Dr Jana Hajslova

Professor Dr Jana Hajslovais a professor at the University of Chemistry and Technology, Prague. She is the head of ISO 17025/2018-accredited laboratory and heads a research group concerned with separation science in the field of food/environmental analysis.

1. Andre CM, Hausman J, Guerriero G. (2016) Cannabis sativa: The Plant of the Thousand and One Molecules. Front plant science, 7: 19. DOI: 10.3389/fpls.2016.000192. Wang M, Wang YH, Avula B, Radwan MM. (2016) Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis and Cannabinoid Research, 1 (1): 262-271. DOI: 10.1089/can.2016.00203. Russo EB. (2019) The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No Strain, No Gain. Front plant science, 9 (9): 1969. DOI: 10.3389/fpls.2018.019694. Morales P, Hurst DP, Reggio PH. (2017) Molecular Targets of the Phytocannabinoids: A Complex Picture. Progress in the Chemistry of Organic Natural Products, 103: 103-131. DOI: 10.1007/978-3-319-45541-9_45. What You Need to Know (And What Were Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD U.S. Food and Drug Administration (Internet), 2019. https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis (accessed January 20, 2020)6. Hazekamp A. (2018) The Trouble with CBD Oil. Medical Cannabis and Cannabinoids, 1: 65-72. DOI: 10.1159/0004892877. European Food Safety Authority (EFSA). (2008) Polycyclic Aromatic Hydrocarbons in Food Scientific Opinion of the Panel on Contaminants in the Food Chain. EFSA Journal, 724: 1-114. DOI: 10.2903/j.efsa.2008.7248. Warning for consumers of CBD and cannabis oils sold on the EU market International Cannabis and Cannabinoids Institute (Internet), 2018. https://www.icci.science/en/article (accessed January 20, 2020)9. Press Release: CBD cannabis oil producers are improving, risks for customers remain International Cannabis and Cannabinoids Institute (Internet), 2018. https://www.icci.science/en/article/news/warning-for-consumers-of-cbd-and-cannabis-oils-sold-on-the-eu-market/ (accessed January 20, 2020)10. Pavlovic R, Nenna G, Calvi L, Panseri S, Borgonovo G, Giupponi L, Cannazza G, Giorgi A. (2018) Quality Traits of Cannabidiol Oils: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations. Molecules, 23 (5). DOI: 10.3390/molecules23051230.11. European Food Safety Authority (EFSA). (2020) Acute human exposure assessment to tetrahydrocannabinol (9THC). EFSA Journal, 18 (1): 5953. DOI: 10.2903/j.efsa.2020.595312. Ayyildiz EG, Esen F. (2020) Atmospheric Polycyclic Aromatic Hydrocarbons (PAHs) at Two Sites, in Bursa, Turkey: Determination of Concentrations, GasParticle Partitioning, Sources, and Health Risk. Archives of Environmental Contamination and Toxicology. DOI :10.1007/s00244-019-00698-713. Franco CFJ, de Resende MF, de Almeida FL, Brasil TF, Eberlin MN, Netto ADP. (2017) Polycyclic aromatic hydrocarbons (PAHs) in street dust of Rio de Janeiro and Niteri, Brazil: Particle size distribution, sources and cancer risk assessment, Science of The Total Environment, 599-600: 305-313. DOI: 10.1016/j.scitotenv.201714. European Monitoring Centre for Drugs and Drug Addiction (2018), Cannabis legislation in Europe: an overview, Publications Office of the European Union, Luxembourg. DOI: 10.2810/56665015. Plant variety database European Commission (Internet). European Commission website, 2018. https://ec.europa.eu/food/plant/ (accessed January 20, 2020).16. Novel food catalogue (Internet). European Commission, 2015. https://ec.europa.eu/food/ (accessed January 20, 2020)

View original post here:

Ensuring the safety of THC dosage in CBD oils - New Food

Last week the FSA issued its first ever CBD safety advice for consumers, along with a stark warning to manufacturers, setting a deadline for businesses to provide more information about the contents of their CBD products.

Cannabis Professionals (CannaPro UK) is a trade association for the UKs cannabis, CBD and hemp businesses, representing the sector to the authorities and offering guidance and support to businesses. The organisation is backed by CLEAR Cannabis Law Reform, the UKs longest-standing cannabis policy group.

Medical Cannabis Network spoke to passionate advocate for the UK cannabis industry Peter Reynolds, of CannaPro UK, about the ruling, and what this means for the CBD industry.

Currently, CBD is recognised as a novel food product, a decision which followed on from the direction of theEuropean Commission (EC). The EC provided its view in January 2019 that CBD products, and products containing it, should be considered a Novel Food. A Novel Food is defined as food that had not been consumed to a significant degree by humans in the EU before 15 May 1997.

Reynolds said: In one sense this announcement is good as now the industry knows where it stands. It was in 2017 that I first started talking to the FSA and they have changed their minds repeatedly, shifting its position over and over again. Finally, they have now actually done something.

Current news about CBD harming the liver is based on CBDs effects in animal studies where the dosages were up to 2500 milligrammes per kilogramme of body weight. Its also based on Epidyolexs prescribing information, where the dosages are up to 20 milligrammes per kilogrammes of body weight. The maximum recommended dose for CBD food supplements is 200 milligrammes. So, the differences are so vast they are just absurd.

The whole thing is preposterous. The FSA has failed to respond to any correspondence from CannaPro for the past six months. They obviously feel under pressure to do something.

They have used the phrase novel, but these products are not novel. I think anybody selling whole CBD extract products can just continue. The crucial part is that if they really had any genuine concern about safety, how could they possible give people only a year to submit an application?

Reynolds said: My involvement is much, much wider than just CBD, and I have long argued that cannabis in all its forms needs a separate regulator the same as it has in the Netherlands, the same as it now has in Germany, and the US states.

It cant be regulated in the same way as single molecule pharmaceutical medicines as it has nearly 400 or 500 molecules it is a completely different type of substance.

A UK cannabis regulation authority would also deal with the problem of prescribing medicinal cannabis because, instead of trying to shoehorn it into a system that just doesnt fit, we can come up with a range of regulations that properly deal with cannabis and its real risks and issues such as making sure it doesnt contain contaminants and heavy metals, and making sure that THC levels are controlled.

Thats what the solution is a cannabis regulation authority, which could deal with medicinal cannabis and CBD.

CannaPro is currently working in conjunction with a barrister to publish detailed guidance in March for its members on how to respond to the novel foods announcement form the FSA.

Here is the original post:

CannaPro: the only solution for CBD is a UK cannabis regulation authority - Health Europa

Collagen encompasses a broad range of ingredients and categories. Collagen can be used in bone health, joint health, nutricosmetic, cosmetic, and even sports nutrition products. Considering the broad range of applications and potential customers, it should be of no surprise that collagen ingredients saw impressive sales growth in the last year. According to market researcher SPINS (Chicago), collagen saw cross-channel (natural, specialty gourmet, and multi-outlet/mainstream channel) dollar growth of 82.7%, increasing $66 million to $147 million during the 52 weeks ending October 6, 2019.

Collagen saw the greatest sales growth in the natural and specialty gourmet channelswhich SPINS terms innovation channelswhere a great deal of product trends show up before going mainstream. In the natural channel, collagen ranked as the 5th bestselling ingredient overall, with 2019 sales growing 59.6% over the previous year to reach $59 million. Within specific product categories in the natural channel, collagen found itself in two of last years top-selling health arenas: bone health and hair/skin/nails. During that time, collagen sales in the natural channel grew 7.9% to $1.5 million in the bone health category and grew an impressive 36.6% to $19.5 million in the hair/skin/nails category. Meanwhile, over in the specialty gourmet channel, collagen sales increased 88.2% overall to $2.8 million last year. Within two of the specialty channels top-selling categoriesbone health and hair/skin/nailscollagen also performed well.

While collagen did not make it to SPINSs list of the top-25-selling mainstream ingredients, collagen was an impressive performer in some mainstream health categories. Within the top mainstream categories of bone health, joint health, and hair/skin/nails, collagen saw significant sales growth. Collagen saw the greatest growth in the bone health category, increasing by 82% to $2.9 million. In the joint health category, collagen sales stayed mostly the same, increasing by 1.7% to $7.4 million. And, once again, hair/skin/nails saw huge growth in the mainstream channel, increasing 54.8% to $42 million.

A common thread between all three channels is that collagen products are performing exceptionally well in the nutricosmetics space.

Why? Consider that the baby boomer population is well into middle age, and Generation X has also entered their early middle years. As with these two generations, millennials have also demonstrated a significant interest in maintaining a healthy, youthful appearance, explains Gene Bruno, senior director of product innovation for supplements brand Twinlab Consolidated Corp. Collagen is well understood to help promote youthful-looking skin, and there is a great deal of media interest in the topic.

Collagen has a number of advantages as an ingredientone them being that it is easy to incorporate into ones diet in a number of ways. Collagen powder, for example, is easy to mix into foods and beverages. Collagen powders are currently the most popular overall delivery form, although weve found that there are generational differences in terms of buyer preference, Bruno explains. For instance, he says, collagen powders are most popular among women 25 or older who value convenience. Twinlabs Reserveage product, Collagen Booster, in capsules, tends to be preferred by women 35 or olderthe reason being that it benefits not only the skins health but also the joints.

Collagen also fits into a number of diets. What we know is that diets such as keto and paleo are driving significant traffic searches on our site, says Bruno. All of our collagen products are keto- and paleo-friendly, so it makes sense that people would incorporate it into their diets.

As a bone health ingredient, collagen is also well-suited for multi-ingredient formulations, allowing for a full spectrum of bone as well as joint health benefits.

Arguably, calcium and vitamin D are the top-selling bone health ingredients, while glucosamine and chondroitin are the top-selling joint health ingredientsalthough they are losing popularity in the marketplace, says Bruno. Whats cool about collagen is that this single ingredient has applications for both bone and joint health and can be used alongside of the aforementioned nutraceuticals, or used independently. Specific collagen peptides have been shown to promote bone mineral density and bone markers in postmenopausal women, while other collagen materials have demonstrated efficacy in supporting joint health and comfort.

2020 Ingredient Trends to Watch for Food, Drinks, and Dietary Supplements:

CBDElderberryMelatoninMCTsMagnesiumAshwagandhaCollagenDietary Fiber/Prebiotics

See the original post here:

Collagen sales skyrocketing thanks to the ingredient's many applications: 2020 Ingredient trends to watch for foods, drinks, and dietary supplements -...